Decubitus Ulcer Ointment Merging Skin Protectant and Antibiotic Functions

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing treatments for decubitus ulcers are either unsuitable, complex, or expensive, lacking a simple and cost-effective composition for effective management.

Innovation Solution

A combination ointment composition comprising a skin protectant, rash cream, and antibiotic ointment, including active ingredients like petroleum, lanolin, dimethicone, zinc oxide, polymyxin B sulfate, and neomycin, along with inactive ingredients such as cod liver oil and virgin olive oil, is developed for treating decubitus ulcers, which is simple to manufacture and apply.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing compositions for treating decubitus ulcers are used, then treatment effect is achieved, but manufacturing complexity and cost increase

Engineering Contradiction:
Improvetreatment effectVSAvoidmanufacturing complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent combines multiple functional components (skin protectant ointment, rash cream, antibiotic ointment, virgin olive oil, and boric acid powder) into a single integrated composition. This merging approach consolidates multiple treatment functions into one product, simplifying manufacturing processes and reducing overall complexity while maintaining comprehensive treatment effectiveness for decubitus ulcers.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The composition is designed to perform multiple functions simultaneously: protection, soothing, and antimicrobial action. By creating a multi-functional formulation that addresses various aspects of ulcer treatment in a single product, the patent reduces the need for multiple separate treatments, thereby simplifying manufacturing and application while improving overall treatment reliability.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Reliability

If existing compositions for treating decubitus ulcers are used, then treatment effect is achieved, but manufacturing cost increases

Engineering Contradiction:
Improvetreatment effectVSAvoidmanufacturing cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent employs cost-effective ingredients such as virgin olive oil and boric acid powder, which are relatively inexpensive compared to many pharmaceutical alternatives. By incorporating these affordable yet effective components, the composition achieves reliable treatment results while maintaining economical manufacturing costs, making the treatment accessible and cost-effective.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

By merging multiple functional ingredients into a single composition, the patent optimizes the formulation to achieve maximum treatment effectiveness while minimizing the total material cost. This consolidated approach allows for more efficient manufacturing processes and reduced overall production costs compared to producing and managing multiple separate treatment products.

Inventive Principle:
Principle #5Merging (Combining)

3Reliability

If complex compositions are used for treating decubitus ulcers, then treatment effectiveness is improved, but ease of use decreases

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidease of use
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent combines multiple treatment functions into a single easy-to-apply composition. Instead of requiring patients to manage multiple separate products, the merged formulation provides protection, soothing, and antimicrobial properties in one application, significantly improving ease of use while maintaining comprehensive treatment effectiveness.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The multi-functional composition is designed to be simple and straightforward to apply, with a unified formulation that delivers multiple benefits simultaneously. This approach eliminates the complexity of managing multiple separate treatments, making the therapy more accessible and easier to perform while maintaining high treatment effectiveness.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition effectively protects the wound, promotes healing, and reduces infection risk, making it a cost-effective and user-friendly solution for decubitus ulcer treatment.

Implementation Method 1

The composition includes a skin protectant ointment... comprising active ingredients petroleum 53.4%, lanolin 15.5%

Methodology Applied
Scientific EffectPhysical barrier formation:

Implementation Method 2

The antibiotic ointment includes active ingredients polymyxin B sulfate 5,000 units, bacitracin zinc 400 units, and neomycin base (as sulfate) 3.5 mg.

Methodology Applied
Scientific EffectAntibacterial action:

Implementation Method 3

The composition further comprises virgin olive oil and boric acid powder

Methodology Applied
Scientific EffectAntimicrobial action:

Data Source

PatentUS7655717B2Ointment composition for treating decubitus ulcers and methods for its making and its use
Publication Date: 2010.02.02 GOULBOURNE MARY J

AI summary

An ointment composition for treating decubitus ulcers and methods for its making and its use. The composition includes a skin protestant ointment, a rash cream, an antibiotic ointment, virgin olive oil, and boric acid powder. The skin protestant ointment includes active ingredients petroleum 53.4%, lanolin 15.5%, and inactive ingredients cod liver oil containing vitamin A & vitamin D, a fragrance, light mineral oil, microcrystalline wax, and paraffin. The rash cream includes active ingredients dimethicone 1% and zinc oxide 10%, and inactive ingredients aloe barbadensis extract, benzyl alcohol, coconut oil, cod liver oil containing vitamin A & vitamin D, a fragrance, glycerol oleate, light mineral oil, ozokerite, paraffin, propylene glycol, sorbitol, synthetic beeswax, and water. The antibiotic ointment includes active ingredients polymyxin B sulfate 5,000 units, bacitracin zinc 400 units, and neomycin base (as sulfate) 3.5 mg., and an inactive ingredient white petroleum.